In 2014, the "new healthcare marketing" will become more discontinuous from the old
When an FDA advisory panel met last month to vote on whether to recommend approval of Sanofi's MS drug Lemtrada, patient opinion leaders had already voiced their view.
The Centers for Medicare and Medicaid Services (CMS) unveiled a new research tool last month.
As I pull out my crystal ball, I see a day where we WANT to use secondary research first
The next generation of drugs sees a number of market access challenges
Eli Lilly is tapping Humana's claims database for therapeutic study
The American College of Cardiology (ACC) said it's entered an agreement to cull insights from a healthcare database
The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential to accelerate the research process.
The partnership seeks to improve medication adherence through predictive analytics.
A quiet revolution is underway in research to keep pace with changes in medical marketing
Symphony Health Solutions filed an antitrust lawsuit against IMS Health, accusing it of trying to monopolize the pharma data and analytics market
The NIH said it will fund up to $24 million per year for four years to establish six to eight Big Data to Knowledge (BD2K) Centers of Excellence
The best-selling book "The End of Illness" illustrates an exciting new way to think of healthcare—and healthcare marketing research
Private equity firm Symphony Technology Group acquired several divisions of United BioSource Corp.
Memoto's tiny clip-on camera provides a detailed timeline of a patient's daily activities
For the client-side market researcher, "doing more with less" is a mantra, if not a corporate way of life
A study, offers for the first time, according to researchers, empirical evidence of the link between a company's culture from a commercial-operations standpoint and revenue performance.
Double-digit growth and a fragmented healthcare system in India have spurred consultancies and data firms, although experts say pricing for services varies widely.
For all the advances in technology and methodology, qualitative research cannot shed its history like its quant sibling
Athenahealth has wasted little time in putting its mark on Epocrates
Fiscal concerns are paramount in the rise of Big Data within healthcare, according to a recent McKinsey analysis, but clinical trends also play a role
"External drivers" can have a significant impact on determining the answer to your marketing question
Healthcare data and analytics giant IMS Health bought Seattle-based software-as-a-service (SaaS) company Appature.
New York University is forming a Center for Data Science, plus a master's-level degree program to prepare the next generation of data professionals
Marketing teams are not going to succeed in the future without a real understanding of the real world
"The marketing research community should be very satisfied with the additional guidance on the Sunshine Act from CMS," said the PMRG's government affairs committee chair
GSK Consumer Health Care is the newest member of a research organization that conducts experiments into how shoppers think and behave.
A foundational premise of agency-of-record and preferred-provider relationships has a fatal flaw
Pfizer and clinical data outfit Humedica jointly announced their intent to collaborate on studies examining the effectiveness of treatments.
Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.
As it became evident that a large HCV+ cohort would likely need medical intervention, pharma responded
PatientsLikeMe, the online patient network and research platform, appointed Daphne Psacharopoulos to the new position of VP, client services and strategic initiatives
Law firm Morrison & Foerster launched a that indexes average up-front payments in agreements between biotech companies and companies that pay for commercialization rights.
In 2012, the phrase "pharmaceutical marketing research" seems a little wrong
Bristol-Myers Squibb is laying off close to 100 employees, including market researchers, as it recovers from patent expiries and awaits new approvals.
Pharma marketing researchers should provide actionable recommendations to brand managers and be more proactive in identifying opportunities to research business issues, said TGaS Advisors.
Marketing continues to be a secondary consideration in the development process
Life science firms are starting to realize that most of the innovation unleashed by Big Data will happen through incremental, bottom-up changes rather than the top-down kind.
Software-as-a-service (SaaS) provider Appature has signed up several healthcare marketing agencies to use its cloud-based relationship marketing tool.
Prescribing remains important, but it's half the picture: pharma's ultimate customer is the patient
Budgets of pharmaceutical marketing research teams are starting to recover, one analyst firm found.
Healthcare marketing research firm WorldOne expanded its board of directors with the addition of Kerry Hicks, the founder and former CEO of HealthGrades
These steps can equip sales teams to work around limited access, bring value to oncologists and increase sales
IMS Health acquired TTC, a Philadelphia-based trial benchmarking and analytics firm
CarbonSix said it launched a tool that can deliver "in the moment" insight about patients living with chronic medical conditions.
Most stakeholders have little or no knowledge of the Act's 1,500 pages of specifics or their implications
Healthcare data firm WorldOne has acquired Sermo
EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA
In a fast-changing industry, a constant is how the limited number of patients for trials hinders drug development
Symphony Technology Group, a private equity firm, acquired the healthcare analytics business of Wolters Kluwer, the companies said.